UKPDS Outcomes Model manual available online
The UKPDS Outcomes Model manual is now available online providing a more detaile view of its functionality and likely uses.
UKPDS Outcomes Model 1.1 released
Reporting of diabetes on death certificates
Reporting of diabetes on death certificates using data from the UK Prospective Diabetes Study
Non-HDL Cholesterol Is Less Informative
Non-HDL Cholesterol Is Less Informative Than the Total-to-HDL Cholesterol Ratio in Predicting Cardiovascular Risk in Type 2 Diabetes
Rury R. Holman, Ruth L....
UKPDS paper 72 published in Diabetologia
Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72)
Glycaemic control after addition of sulphonylurea to metformin
Glycemic Control Continues to Deteriorate After Sulfonylureas Are Added to Metformin Among Patients With Type 2 Diabetes
Michael N Cook, Cynthia J Girman, Peter P Stein, Charles M Alexander & Rury R Holman
Diabetes Care (2005); 28: 995-1000
OBJECTIVE— To describe the course and predictors of glycemic control among patients with type 2 diabetes after sulfonylureas (SUs) are added to metformin (MF).
RESEARCH DESIGN AND METHODS— Patients (n 2,220) treated with MF monotherapy for 90 days before initiating MF plus SU combination therapy between January 1998 and March 2004 were studied in a retrospective analysis of electronic medical records from U....
UKPDS paper 70 published in Diabetologia
Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control
UKPDS paper 71 published in Diabetologia
IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes
UKPDS paper 67 published in Diabetic Medicine
Insulin sensitivity at diagnosis of Type 2 diabetes is not associated with subsequent cardiovascular disease (UKPDS 67).
Framingham risk equations can underestimate CHD risk in diabetes
Framingham risk equations underestimate coronary heart disease risk in diabetes